-
Postpartum Depression Drug Market to Reach USD 62.29B by 2032, FDA-Approved SSRIs, Brexanolone, Zuranolone Trends
23 Oct 2025 11:23 GMT
… of PPD simultaneously. Personalized medicine, tailoring treatment based on … effects beyond a month. Medication and pharmacotherapy segments dominate the market, … Mental Health Treatments
Leading the global PPD drugs market, Sun Pharmaceuticals, Cipla Inc …
-
Toxic Trade: India’s Generic Drug Empire and the Hidden Dangers in America’s Medicine Cabinet
23 Oct 2025 14:00 GMT
… foreign manufacturers for generic drugs and key medical ingredients.
By yourNEWS … such as Sun Pharma, Dr. Reddy’s, Lupin, Cipla, and Aurobindo … pharmaceutical sector.
Incidents involving contaminated or adulterated medicines have raised public health …
-
Indian pharma giant Cipla inks deal to sell Eli Lilly’s weight-loss drug under a different brand name: Why is this significant?
23 Oct 2025 14:02 GMT
… pharma giant Cipla on Thursday announced an agreement with US pharmaceutical … blockbuster weight-loss drug Mounjaro. The drug, which was … least one weight-related health condition, such as high … the introduction of innovative medicines and expand access to …
-
Cipla to sell Eli Lilly’s weight-loss drug as Yurpeak in India
23 Oct 2025 12:43 GMT
… signed an agreement with Cipla, allowing the Indian drugmaker to sell its … , Lilly will manufacture the drug and Cipla will market it under the … healthcare providers to personalise treatment plans to individual patient needs.
The medication …
-
Eli Lilly allows Cipla to sell weight loss drug under new brand in India
23 Oct 2025 11:14 GMT
… , Lilly will manufacture the drug and Cipla will market it under the … healthcare providers to personalise treatment plans to individual patient needs.
The medication … as Mounjaro.
India’s Torrent Pharma to proceed with $1.6bn …
-
Cipla, Bajaj Finserv, Tata Motors Share Price Jumps as NSE Nifty Trades at All-Time Highs
23 Oct 2025 05:33 GMT
… time highs.
Cipla Ltd: Pharma Stability Meets Technical Breakout
Cipla has entered an … -Term Catalyst
Analyst Sentiment
Outlook
Cipla
Pharmaceuticals
Q2 results (Oct 30)
… seeking large-cap resilience, Cipla offers dependable defensiveness with technical …
-
Pharma stocks in focus as Trump eyes probe into foreign drug pricing practices
23 Oct 2025 04:29 GMT
… ordered an investigation into foreign drug pricing practices. According to Reuters … market. Other major exporters include Cipla (29 per cent), Dr. Reddy … issued letters to 17 pharmaceutical firms demanding lower Medicare prices within 60 …
-
Pills, profits and peril: How India’s export-driven pharma machine puts Americans at severe risk
21 Oct 2025 17:00 GMT
… firms to reverse-engineer Western drugs without licensing fees. That loophole … ” vials of injectable medication that still reached U.S. pharmacies. Yet the … Aurobindo USA), Intas (via Accord Healthcare), Cipla and Glenmark. Most anchor their …
-
Top Gainers & Losers on Muhurat trading: Bajaj Finserv, Cipla, Infosys, DCB Bank, Tata Investment among top gainers
21 Oct 2025 18:29 GMT
… and Sensex included Bajaj Finserv, Cipla, Infosys, Axis Bank, and JSW … Bank, JM Financial, Shoppers Stop, HealthCare Global Enterprises, MTAR Technologies, and …
-
Pharma Q2 preview: Steady growth despite US sales pressure, GST rate cuts
21 Oct 2025 00:17 GMT
… of 100% tariffs on pharma imports skipped generic drugs, uncertainty over the … that of blood thinning medicine Xarelto—by Aurobindo Pharma and Lupin Ltd … 180-day exclusivity for the drug.
Cipla saw strong market share gain …
About
© 1995-2025